NCT07644702 · Mayo Clinic
WE-CARE Community Health Forums to Increase Breast Cancer Screening and Clinical Trial Participation for Rural and Low Income Women
What this study is about
This clinical trial tests how well the Women's Engagement for Cancer Awareness, Resources, and Education (WE-CARE) community health forums work to increase breast cancer screening and clinical trial participation for rural and low income women.
View original scientific description
This clinical trial tests how well the Women's Engagement for Cancer Awareness, Resources, and Education (WE-CARE) community health forums work to increase breast cancer screening and clinical trial participation for rural and low income women. Despite advances in breast cancer diagnosis and treatment in the past decade, rural-dwelling and underserved women, and Black, Indigenous, and people of color continue to experience low rates of breast cancer screening. Since the survival rate for breast cancer is largely dependent on stage at which it is diagnosed, later stage breast cancer is correlated to a poorer prognosis and higher mortality rate. The WE-CARE community health forms address structural barriers through culturally tailored educational sessions on breast cancer risk, screening and clinical trials, survivor storytelling to humanize cancer and research and patient navigation to facilitate mammogram screening and address barriers. The WE-CARE community health forums may be an effective way to increase breast cancer screening and clinical trial participation for rural and low income women.
Interventions
OTHER
Educational Intervention
Attend education sessions at WE-CARE forum
BEHAVIORAL
Patient Navigation
Receive navigation support
OTHER
Supportive Care
Attend storytelling sessions at WE-CARE forum
Primary outcome measures
Recruitment yield
Time frame: At time of forum
Assessed via the number enrolled divided by the number of eligible participants approached.
Exposure reach (community level reach)
Time frame: At time of forum
Assessed by the number of attendees divided by the estimated number of population indirectly exposed (e.g., via flyers, social media, community announcements).
Retention
Time frame: From baseline to 3 months
Assessed by the number of participants who complete 3-month follow-up.
Perceived participant satisfaction
Time frame: Immediately following completion of forum
Success is defined as ≥ 75% of participants rating the experience ≥ 4 on a 5-point scale rated on a 5-point scale where 1=strongly disagree and 5=strongly agree. Higher scores indicate greater perceived satisfaction.
Perceived barriers to engagement and community impact
Time frame: Immediately following completion of forum
Assessed by post-intervention focus groups and brief qualitative interviews. Results will be analyzed descriptively.
Perceived facilitators to engagement and community impact
Time frame: Immediately following completion of forum
Assessed by post-intervention focus groups and brief qualitative interviews. Results will be analyzed descriptively.
Perceived acceptability - AIM
Time frame: Immediately following completion of forum
Assessed using the Acceptability of Intervention Measure (AIM), which consists of 4 items (e.g., meets my approval, is appealing to me) each rated on a 5-point scale where 1=strongly disagree and 5=strongly agree. Higher scores indicate greater perceived acceptability.
Perceived appropriateness - IAM
Time frame: Immediately following completion of forum
Assessed using the Intervention Appropriateness Measure (IAM), which consists of 4 items (e.g., seems fitting, seems like a good match) each rated on a 5-point scale where 1=strongly disagree and 5=strongly agree.
Perceived feasibility - FIM
Time frame: Immediately following completion of forum
Assessed using the Feasibility of Intervention Measure (FIM), which consists of 4 items (e.g., seems implementable, seems easy to use) each rated on a 5-point scale where 1=strongly disagree and 5=strongly agree. Higher scores indicate greater perceived acceptability.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Be between the ages of 50 and 74 years
- Have no prior history of breast cancer screening (i.e., who have either never received a mammogram or have not had one in the past five years)
- Reside in a rural community in Wisconsin or belong to low income (self-reported)
- Be able to speak and understand English or Spanish
- Be willing and able to provide informed consent
Exclusion criteria
- Women who have received a mammogram within the past five years
- Have a current or prior diagnosis of breast cancer
- Are currently undergoing treatment for any active malignancy
- Have cognitive or psychiatric impairments that, in the judgment of the study team, would preclude meaningful participation
Where
- Eau Claire, Wisconsin
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jun 12, 2026 · Source of record for eligibility and locations